Regenxbio stated that it has reached a consensus with the U.S. Food and Drug Administration (FDA) on the next steps needed for potential accelerated approval of the gene therapy Naxsunli.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
A company spokesperson stated that both parties have clarified the direction for subsequent actions, laying the foundation for advancing the review process of the therapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Alcoa breaks ground on gallium production plant at Wagerup refinery in Western Australia
Reuters•2026/08/24 09:48
Beiersdorf releases transcript of FY 2025 results conference call
Reuters•2026/08/24 09:47
Equifax Canada sees Canadian consumer debt rise to $2.68 trillion in Q2 2026
Reuters•2026/08/24 09:45
Crypto prices
MoreBitcoin
BTC
$77,566.02
+1.27%
Ethereum
ETH
$2,464.56
+2.10%
Tether USDt
USDT
$0.9998
-0.01%
XRP
XRP
$1.48
+0.41%
USDC
USDC
$1
+0.01%
Solana
SOL
$94.74
+1.46%
TRON
TRX
$0.3438
+0.28%
Hyperliquid
HYPE
$78.46
-0.86%
Dogecoin
DOGE
$0.09127
+0.19%
Zcash
ZEC
$831.21
+3.25%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now